Increased Transparency for Pharmaceutical Research Costs
New legislation increases public access to information about the costs of drug clinical trials and pharmaceutical companies' development spending. This aims to help citizens better understand drug prices by making data on development costs available.
Key points
Companies conducting drug clinical trials must post detailed cost data for these trials on a public website.
Publicly traded drug manufacturers must disclose their annual drug research and development expenditures in financial reports, broken down by development stage.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.